Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nathalie Garçon & Marcelle Van Mechelen. (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Review of Vaccines 10:4, pages 471-486.
Read now
Read now
Julio Vladimir Cruz-Chan, Miguel Rosado-Vallado & Eric Dumonteil. (2010) Malaria vaccine efficacy: overcoming the helminth hurdle. Expert Review of Vaccines 9:7, pages 707-711.
Read now
Read now
Blaise Genton. (2008) Malaria vaccines: a toy for travelers or a tool for eradication?. Expert Review of Vaccines 7:5, pages 597-611.
Read now
Read now
Articles from other publishers (62)
Srinivasa Reddy Bonam, Laurent Rénia, Ganesh Tadepalli, Jagadeesh Bayry & Halmuthur Mahabalarao Sampath Kumar. (2021) Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants. Vaccines 9:10, pages 1072.
Crossref
Crossref
Sylvester Dassah, Bright Adu, Sodiomon B. Sirima, Benjamin Mordmüller, Ulysse Ateba Ngoa, Frank Atuguba, Fareed K.N. Arthur, Benedicta A. Mensah, Mark Kaddumukasa, Peter Bang, Peter G. Kremsner, Donnie Mategula, Clare Flach, Paul Milligan & Michael Theisen. (2021) Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine. Vaccine 39:31, pages 4314-4319.
Crossref
Crossref
Isabel G. Azcárate, Patricia Marín-García, Paloma Abad, Susana Pérez-Benavente, Estela Paz-Artal, Pedro A. Reche, Julius N. Fobil, José M. Rubio, Amalia Diez, Antonio Puyet & José M. Bautista. (2020) Plasmodium falciparum immunodominant IgG epitopes in subclinical malaria. Scientific Reports 10:1.
Crossref
Crossref
N. MojganiY. ShahaliM. Dadar. (2020) Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development. Beneficial Microbes 11:3, pages 213-226.
Crossref
Crossref
W. Ripley Ballou & Johan Vekemans. 2018. Plotkin's Vaccines. Plotkin's Vaccines
561
566.e3
.
Maiga Hamma. (2016) Impact of seasonal malaria chemoprevention of sulphadoxinepyrimethamine plus amodiaquine on molecular markers resistance of Plasmodium falciparum malaria: A review in West Africa. Clinical Reviews and Opinions 7:1, pages 1-10.
Crossref
Crossref
Danica A. Helb, Kevin K. A. TettehPhilip L. FelgnerJeff SkinnerAlan HubbardEmmanuel ArinaitweHarriet Mayanja-KizzaIsaac SsewanyanaMoses R. KamyaJames G. BeesonJordan TapperoDavid L. Smith, Peter D. CromptonPhilip J. RosenthalGrant DorseyChristopher J. DrakeleyBryan Greenhouse. (2015)
Novel serologic biomarkers provide accurate estimates of recent
Plasmodium falciparum
exposure for individuals and communities
. Proceedings of the National Academy of Sciences 112:32.
Crossref
Crossref
Deborah A. Garside, Reinaldo Acevedo, Manal Alsaadi, Natalie Nimmo, Ayman Gebril, Dimitrios Lamprou, Alexander B. Mullen & Valerie A. Ferro. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
221
250
.
L. Karthik, Gaurav Kumar, Tarun Keswani, Arindam Bhattacharyya, S. Sarath Chandar & K. V. Bhaskara Rao. (2014) Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound. PLoS ONE 9:3, pages e90972.
Crossref
Crossref
Lander Foquet, Cornelus C. Hermsen, Geert-Jan van Gemert, Eva Van Braeckel, Karin E. Weening, Robert Sauerwein, Philip Meuleman & Geert Leroux-Roels. (2013) Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. Journal of Clinical Investigation 124:1, pages 140-144.
Crossref
Crossref
Philip L. Felgner, Meta Roestenberg, Li Liang, Christopher Hung, Aarti Jain, Jozelyn Pablo, Rie Nakajima-Sasaki, Douglas Molina, Karina Teelen, Cornelus C. Hermsen & Robert Sauerwein. (2013) Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Scientific Reports 3:1.
Crossref
Crossref
Xiaoyan Zou, Brent L House, Michael D Zyzak, Thomas L Richie & Vincent R Gerbasi. (2013) Towards an optimized inhibition of liver stage development assay (ILSDA) for Plasmodium falciparum. Malaria Journal 12:1.
Crossref
Crossref
L. von Seidlein & P. Bejon. (2013) Malaria vaccines: past, present and future. Archives of Disease in Childhood 98:12, pages 981-985.
Crossref
Crossref
Kae Pusic, Danielle Clements, Sophie Kobuch & George Hui. (2013) Antibody and T Cell Responses in Reciprocal Prime-Boost Studies with Full-Length and Truncated Merozoite Surface Protein 1–42 Vaccines. PLoS ONE 8:9, pages e75939.
Crossref
Crossref
Upma Bagai & Anil Pawar. (2013) A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice. Parasitology International 62:3, pages 329-336.
Crossref
Crossref
W. Ripley Ballou & Joe Cohen. 2013. Vaccines. Vaccines
1133
1137
.
Michael B. Doud, Adem C. Koksal, Li-Zhi Mi, Gaojie Song, Chafen Lu & Timothy A. Springer. (2012) Unexpected fold in the circumsporozoite protein target of malaria vaccines. Proceedings of the National Academy of Sciences 109:20, pages 7817-7822.
Crossref
Crossref
Josea Rono, Anna Färnert, Daniel Olsson, Faith Osier, Ingegerd Rooth & Kristina E. M. Persson. (2012)
Plasmodium falciparum Line-Dependent Association of
In Vitro
Growth-Inhibitory Activity and Risk of Malaria
. Infection and Immunity 80:5, pages 1900-1908.
Crossref
Crossref
Xin-zhuan Su & Deirdre A. Joy. 2012. Genome Plasticity and Infectious Diseases. Genome Plasticity and Infectious Diseases
267
285
.
Afsaneh Motevalli Haghi, Mohammad Reza Khoramizade, Mehdi Nateghpour, Mehdi Mohebali, Gholam Hossein Edrissian, Mohammad Reza Eshraghian & Zargham Sepehrizadeh. (2012) A Recombinant Plasmodium vivax Apical Membrane Antigen-1 to Detect Human Infection in Iran. The Korean Journal of Parasitology 50:1, pages 15-21.
Crossref
Crossref
ZI SANG, ZHIPENG QIU, QINGKAI KONG & YUN ZOU. (2012) ASSESSMENT OF VECTOR CONTROL AND PHARMACEUTICAL TREATMENT IN REDUCING MALARIA BURDEN: A SENSITIVITY AND OPTIMAL CONTROL ANALYSIS. Journal of Biological Systems 20:01, pages 67-85.
Crossref
Crossref
Lynne S. Garcia. 2012. Non-Neoplastic Hematopathology and Infections. Non-Neoplastic Hematopathology and Infections
113
137
.
Elke S. Bergmann-Leitner, Patricia M. Legler, Tatyana Savranskaya, Christian F. Ockenhouse & Evelina Angov. (2011) Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS. Vaccine 29:35, pages 5940-5949.
Crossref
Crossref
Lilian Lacerda Bueno, Francisco Pereira Lobo, Cristiane Guimarães Morais, Luíza Carvalho Mourão, Ricardo Andrez Machado de Ávila, Irene Silva Soares, Cor Jesus Fontes, Marcus Vinícius Lacerda, Carlos Chavez Olórtegui, Daniella Castanheira Bartholomeu, Ricardo Toshio Fujiwara & Érika Martins Braga. (2011) Identification of a Highly Antigenic Linear B Cell Epitope within Plasmodium vivax Apical Membrane Antigen 1 (AMA-1). PLoS ONE 6:6, pages e21289.
Crossref
Crossref
Joe Cohen, Sarah Benns, Johan Vekemans, Amanda Leach & Lode Schuerman. 2011. Progress in Parasitology. Progress in Parasitology
121
133
.
Saber Gholizadeh, Hamid Reza Basseri, Sedigheh Zakeri, Hossein Ladoni & Navid Dinparast Djadid. (2010) Cloning, expression and transmission-blocking activity of anti-PvWARP, malaria vaccine candidate, in Anopheles stephensi mysorensis. Malaria Journal 9:1.
Crossref
Crossref
Carole A. Long & Fidel P. Zavala. 2010. The Immune Response to Infection. The Immune Response to Infection
587
597
.
J. Cohen, S. Benns, J. Vekemans & A. Leach. (2010) Le candidat vaccin antipaludique RTS,S/AS est entré en essais cliniques de phase III. Annales Pharmaceutiques Françaises 68:6, pages 370-379.
Crossref
Crossref
Matthew A. Child, Christian Epp, Hermann Bujard & Michael J. Blackman. (2010) Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth. Molecular Microbiology, pages no-no.
Crossref
Crossref
Giorgio Sirugo & Scott M. Williams. (2010) HbS and HbC associate with malaria transmission: Human genetics links to vaccinology?. Vaccine 28:39, pages 6403.
Crossref
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Greta E. Weiss, Boubacar Traore, Kassoum Kayentao, Aissata Ongoiba, Safiatou Doumbo, Didier Doumtabe, Younoussou Kone, Seydou Dia, Agnes Guindo, Abdramane Traore, Chiung-Yu Huang, Kazutoyo Miura, Marko Mircetic, Shanping Li, Amy Baughman, David L. Narum, Louis H. Miller, Ogobara K. Doumbo, Susan K. Pierce & Peter D. Crompton. (2010) The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections. PLoS Pathogens 6:5, pages e1000912.
Crossref
Crossref
Miranda I. Teboh-Ewungkem & Thomas Yuster. (2010) A within-vector mathematical model of Plasmodium falciparum and implications of incomplete fertilization on optimal gametocyte sex ratio. Journal of Theoretical Biology 264:2, pages 273-286.
Crossref
Crossref
Peter D. CromptonMatthew A. Kayala, Boubacar TraoreKassoum KayentaoAissata OngoibaGreta E. WeissDouglas M. MolinaChad R. BurkMichael WaisbergAlgis JasinskasXiaolin TanSafiatou DoumboDidier DoumtabeYounoussou KoneDavid L. Narum, Xiaowu LiangOgobara K. DoumboLouis H. Miller, Denise L. Doolan, Pierre Baldi, Philip L. FelgnerSusan K. Pierce. (2010)
A prospective analysis of the Ab response to
Plasmodium falciparum
before and after a malaria season by protein microarray
. Proceedings of the National Academy of Sciences 107:15, pages 6958-6963.
Crossref
Crossref
Peter D. Crompton, Kazutoyo Miura, Boubacar Traore, Kassoum Kayentao, Aissata Ongoiba, Greta Weiss, Safiatou Doumbo, Didier Doumtabe, Younoussou Kone, Chiung-Yu Huang, Ogobara K. Doumbo, Louis H. Miller, Carole A. Long & Susan K. Pierce. (2010)
In V
itro
Growth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
. Infection and Immunity 78:2, pages 737-745.
Crossref
Crossref
Hayder A. Giha, Amre Nasr, Nnaemeka C. Iriemenam, Halima A. Balogun, David Arnot, Thor G. Theander, Marita Troye-Blomberg, Klavs Berzins & Gehad ElGhazali. (2010) Age-dependent association between IgG2 and IgG3 subclasses to Pf332-C231 antigen and protection from malaria, and induction of protective antibodies by sub-patent malaria infections, in Daraweesh. Vaccine 28:7, pages 1732-1739.
Crossref
Crossref
RICK M. FAIRHURST & THOMAS E. WELLEMS. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3437
3462
.
Miranda I. Teboh-Ewungkem, Chandra N. Podder & Abba B. Gumel. (2009) Mathematical Study of the Role of Gametocytes and an Imperfect Vaccine on Malaria Transmission Dynamics. Bulletin of Mathematical Biology 72:1, pages 63-93.
Crossref
Crossref
Nitchakarn Noranate, Franck Prugnolle, Hélène Jouin, Adama Tall, Laurence Marrama, Cheikh Sokhna, Marie-Thérèse Ekala, Micheline Guillotte, Emmanuel Bischoff, Christiane Bouchier, Jintana Patarapotikul, Jun Ohashi, Jean-François Trape, Christophe Rogier & Odile Mercereau-Puijalon. (2009) Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting. BMC Microbiology 9:1.
Crossref
Crossref
Desmond Slade, Ahmed M. Galal, Waseem Gul, Mohamed M. Radwan, Safwat A. Ahmed, Shabana I. Khan, Babu L. Tekwani, Melissa R. Jacob, Samir A. Ross & Mahmoud A. ElSohly. (2009) Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers. Bioorganic & Medicinal Chemistry 17:23, pages 7949-7957.
Crossref
Crossref
Brent L. House, Michael R. Hollingdale, John B. SacciJr.Jr. & Thomas L. Richie. (2009) Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here?. Trends in Parasitology 25:11, pages 525-533.
Crossref
Crossref
V. ANN STEWART & R. COPPEL. (2009) Issues in malaria vaccine development. Parasite Immunology 31:9, pages 489-491.
Crossref
Crossref
A. M. MOORMANN. (2009) How might infant and paediatric immune responses influence malaria vaccine efficacy?. Parasite Immunology 31:9, pages 547-559.
Crossref
Crossref
V.S. Moorthy, C. Diggs, S. Ferro, M.F. Good, S. Herrera, A.V. Hill, E.B. Imoukhuede, S. Kumar, C. Loucq, K. Marsh, C.F. Ockenhouse, T.L. Richie & R.W. Sauerwein. (2009) Report of a Consultation on the Optimization of Clinical Challenge Trials for Evaluation of Candidate Blood Stage Malaria Vaccines, 18–19 March 2009, Bethesda, MD, USA. Vaccine 27:42, pages 5719-5725.
Crossref
Crossref
Lilian Lacerda Bueno, Cristiane Guimarães Morais, Irene da Silva Soares, Leoneide Erica Maduro Bouillet, Oscar Bruna-Romero, Cor Jesus Fontes, Ricardo Toshio Fujiwara & Érika Martins Braga. (2009) Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells. Vaccine 27:41, pages 5581-5588.
Crossref
Crossref
Kazutoyo Miura, Hong Zhou, Ababacar Diouf, Samuel E. Moretz, Michael P. Fay, Louis H. Miller, Laura B. Martin, Mark A. Pierce, Ruth D. Ellis, Gregory E. D. Mullen & Carole A. Long. (2009)
Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting
Plasmodium falciparum
Growth, as Determined by the In Vitro Growth Inhibition Assay
. Clinical and Vaccine Immunology 16:7, pages 963-968.
Crossref
Crossref
Caroline Kulangara, Andrey V. Kajava, Giampietro Corradin & Ingrid Felger. (2009) Sequence Conservation in Plasmodium falciparum α-Helical Coiled Coil Domains Proposed for Vaccine Development. PLoS ONE 4:5, pages e5419.
Crossref
Crossref
Konstantinos Koussis, Chrislaine Withers-Martinez, Sharon Yeoh, Matthew Child, Fiona Hackett, Ellen Knuepfer, Luiz Juliano, Ute Woehlbier, Hermann Bujard & Michael J Blackman. (2009) A multifunctional serine protease primes the malaria parasite for red blood cell invasion. The EMBO Journal 28:6, pages 725-735.
Crossref
Crossref
Chandima S. K. RajapakseAlberto MartínezBecky NaoulouAndrzej A. JarzeckiLiliana SuárezChristiane DeregnaucourtVéronique SinouJoseph SchrévelElgilda MusiGrazia AmbrosiniGary K. SchwartzRoberto A. Sánchez-Delgado. (2009) Synthesis, Characterization, and in vitro Antimalarial and Antitumor Activity of New Ruthenium(II) Complexes of Chloroquine. Inorganic Chemistry 48:3, pages 1122-1131.
Crossref
Crossref
Caroline Othoro, Dean Johnston, Rebecca Lee, Jonathan Soverow, Jean-Claude Bystryn & Elizabeth Nardin. (2009)
Enhanced Immunogenicity of
Plasmodium falciparum
Peptide Vaccines Using a Topical Adjuvant Containing a Potent Synthetic Toll-Like Receptor 7 Agonist, Imiquimod
. Infection and Immunity 77:2, pages 739-748.
Crossref
Crossref
K. VAUGHAN, M. BLYTHE, J. GREENBAUM, Q. ZHANG, B. PETERS, D. L. DOOLAN & A. SETTE. (2009)
Meta-analysis of immune epitope data for all
Plasmodia
: overview and applications for malarial immunobiology and vaccine-related issues
. Parasite Immunology 31:2, pages 78-97.
Crossref
Crossref
Vincent Pryde Kehdinga Titanji, Alfred Amambua-Ngwa, Damian Nota Anong, Stanley Kimbeng Mbandi, Emily Tangie, Ivo Tening & Raymond Yengo. (2009) Isolation and expression of UB05, a Plasmodium falciparum antigen recognised by antibodies from semi-immune adults in a high transmission endemic area of the Cameroonian rainforest. Clinical Chemistry and Laboratory Medicine 47:9.
Crossref
Crossref
Denise L. Doolan, Carlota Dobaño & J. Kevin Baird. (2009) Acquired Immunity to Malaria. Clinical Microbiology Reviews 22:1, pages 13-36.
Crossref
Crossref
Nnaemeka C. Iriemenam, Atif H. Khirelsied, Amre Nasr, Gehad ElGhazali, Haider A. Giha, Thoraya M. Elhassan A-Elgadir, Ahmed A. Agab-Aldour, Scott M. Montgomery, Robin F. Anders, Michael Theisen, Marita Troye-Blomberg, Mustafa I. Elbashir & Klavs Berzins. (2009) Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. Vaccine 27:1, pages 62-71.
Crossref
Crossref
Carmen Fernandez-Becerra, Marcio M. Yamamoto, Ricardo Z.N. Vêncio, Marcus Lacerda, Anna Rosanas-Urgell & Hernando A. del Portillo. (2009) Plasmodium vivax and the importance of the subtelomeric multigene vir superfamily. Trends in Parasitology 25:1, pages 44-51.
Crossref
Crossref
Matthew N. Davies & Darren R. Flower. 2010. Bioinformatics for Immunomics. Bioinformatics for Immunomics
1
20
.
Danny A. MilnerJrJr, Jacqui Montgomery, Karl B. Seydel & Stephen J. Rogerson. (2008) Severe malaria in children and pregnancy: an update and perspective. Trends in Parasitology 24:12, pages 590-595.
Crossref
Crossref
Peter D. Crompton, Boubacar Traore, Kassoum Kayentao, Safiatou Doumbo, Aissata Ongoiba, Seidina A. S. Diakite, Michael A. Krause, Didier Doumtabe, Younoussou Kone, Greta Weiss, Chiung‐Yu Huang, Seydou Doumbia, Aldiouma Guindo, Rick M. Fairhurst, Louis H. Miller, Susan K. Pierce & Ogobara K. Doumbo. (2008) Sickle Cell Trait Is Associated with a Delayed Onset of Malaria: Implications for Time‐to‐Event Analysis in Clinical Studies of Malaria. The Journal of Infectious Diseases 198:9, pages 1265-1275.
Crossref
Crossref
Ute Frevert & Elizabeth Nardin. (2008)
Cellular effector mechanisms against
Plasmodium
liver stages
. Cellular Microbiology 10:10, pages 1956-1967.
Crossref
Crossref
David R. Cavanagh, Edmond J. Remarque, Robert W. Sauerwein, Cornelus C. Hermsen & Adrian J.F. Luty. (2008) Influenza virosomes: a flu jab for malaria?. Trends in Parasitology 24:9, pages 382-385.
Crossref
Crossref
Catherine Lavazec & Catherine Bourgouin. (2008) Mosquito-based transmission blocking vaccines for interrupting Plasmodium development. Microbes and Infection 10:8, pages 845-849.
Crossref
Crossref
Xuecheng Zhang, Matthew A. Perugini, Shenggen Yao, Christopher G. Adda, Vincent J. Murphy, Andrew Low, Robin F. Anders & Raymond S. Norton. (2008) Solution Conformation, Backbone Dynamics and Lipid Interactions of the Intrinsically Unstructured Malaria Surface Protein MSP2. Journal of Molecular Biology 379:1, pages 105-121.
Crossref
Crossref